FDA Grants Priority Review to Genentech’s Inavolisib NDA in Breast Cancer

… Medicines Agency. Filed under. Precision Oncology · Regulatory News & FDA Approvals · Genentech · North America · Breast Cancer · HER2 Biomarkers.